Literature DB >> 17947531

Distinct gamma interferon-production pathways in mice infected with lactate dehydrogenase-elevating virus.

Thao Le-Thi-Phuong1, Gaëtan Thirion, Jean-Paul Coutelier.   

Abstract

Two distinct pathways of gamma interferon (IFN-gamma) production have been found in mice infected with lactate dehydrogenase-elevating virus. Both pathways involve natural killer cells. The first is mostly interleukin-12-independent and is not controlled by type I interferons. The second, which is suppressed by type I interferons, leads to increased levels of IFN-gamma production and requires the secretion of interleukin-12. This regulation of IFN-gamma production by type I interferons may help to control indirect pathogenesis induced by this cytokine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17947531     DOI: 10.1099/vir.0.83242-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  4 in total

1.  CD66a (CEACAM1) expression by mouse natural killer cells.

Authors:  Gaëtan Thirion; Ana Agusti Feliu; Jean-Paul Coutelier
Journal:  Immunology       Date:  2008-05-17       Impact factor: 7.397

2.  Lactate dehydrogenase-elevating virus induces systemic lymphocyte activation via TLR7-dependent IFNalpha responses by plasmacytoid dendritic cells.

Authors:  Christoph G Ammann; Ronald J Messer; Karin E Peterson; Kim J Hasenkrug
Journal:  PLoS One       Date:  2009-07-01       Impact factor: 3.240

3.  Mouse nidovirus LDV infection alleviates graft versus host disease and induces type I IFN-dependent inhibition of dendritic cells and allo-responsive T cells.

Authors:  Mélanie Gaignage; Reece G Marillier; Catherine Uyttenhove; Nicolas Dauguet; Anubha Saxena; Bernard Ryffel; Thomas Michiels; Jean-Paul Coutelier; Jacques Van Snick
Journal:  Immun Inflamm Dis       Date:  2017-04-04

4.  Lactate dehydrogenase-elevating virus enhances natural killer cell-mediated immunosurveillance of mouse mesothelioma development.

Authors:  Mohamed F Mandour; Pyone Pyone Soe; Catherine Uyttenhove; Jacques Van Snick; Etienne Marbaix; Jean-Paul Coutelier
Journal:  Infect Agent Cancer       Date:  2020-05-07       Impact factor: 2.965

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.